Skip to main navigation Skip to search Skip to main content

LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain

  • Sitki Cem Parlar
  • , Konstantin Senkevich
  • , Eric Yu
  • , Jennifer A. Ruskey
  • , Jamil Ahmad
  • , Farnaz Asayesh
  • , Dan Spiegelman
  • , Cheryl Waters
  • , Oury Monchi
  • , Yves Dauvilliers
  • , Nicolas Dupré
  • , Lior Greenbaum
  • , Sharon Hassin-Baer
  • , Irina Miliukhina
  • , Alla Timofeeva
  • , Anton Emelyanov
  • , Sofya Pchelina
  • , Roy N. Alcalay
  • , Edward A. Fon
  • , Jean François Trempe
  • Ziv Gan-Or*
*Corresponding author for this work
  • McGill University
  • Columbia University
  • University of Calgary
  • Université de Montpellier
  • Université Laval
  • The Gertner Institute
  • Sheba Medical Center at Tel Hashomer
  • Russian Academy of Sciences
  • Pavlov First State Medical University of St. Petersburg
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journalArticlepeer-review

Abstract

LRRK2 variants are key genetic risk factors for Parkinson’s Disease (PD). We conducted a per-domain rare coding variant burden analysis, including 8,888 PD cases and 69,412 controls. In meta-analysis, the Kinase domain was strongly associated with PD (Exonic: PFDR = 1.61 × 10−22, Non-synonymous: PFDR = 1.54 × 10−23, CADD > 20: PFDR = 3.09 × 10−24). Excluding the p.G2019S variant nullified this effect. Nominal associations were found in the ANK and Roc-COR domains, with potentially protective variants, p.R793M and p.Q1353K.

Original languageEnglish
Article number102
Journalnpj Parkinson's Disease
Volume11
Issue number1
DOIs
StatePublished - Dec 2025

Fingerprint

Dive into the research topics of 'LRRK2 rare-variant per-domain genetic burden in Parkinson’s Disease: association confined to the kinase domain'. Together they form a unique fingerprint.

Cite this